Rotella Capital Management »

BioMimetic Therapeutics shares owned by Rotella Capital Management

Quarter-by-quarter ownership of BioMimetic Therapeutics shares owned by Rotella Capital Management from 13F filings

Historical chart of Rotella Capital Management investment in BioMimetic Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including BioMimetic Therapeutics held by Rotella Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMimetic Therapeutics by Rotella Capital Management

Quarter filed Position value Share count Share price at filing
2012-06-30 $42k 16k 2.63

More positions owned by Rotella Capital Management

Spdr S&p 500 Etf (SPY)
SPDR S&P MidCap 400 ETF (MDY)
PowerShares Emerging Markets Sovere
Vanguard Short-Term Bond ETF (BSV)
iShares Lehman 7-10 Yr Treas. Bond (IEF)
PowerShares 1-30 Laddered Treasury
iShares Lehman Aggregate Bond (AGG)
iShares iBoxx $ High Yid Corp Bond (HYG)
SPDR Barclays Capital High Yield B
iShares IBoxx $ Invest Grade Corp Bd (LQD)
iShares Barclays TIPS Bond Fund (TIP)
iShares Barclays 1-3 Year Cred Bd Fd ETF (IGSB)
Vanguard Intermediate-Term Bond ETF (BIV)
Vanguard Total Bond Market ETF (BND)
Vanguard Long-Term Bond ETF (BLV)

View all positions for Rotella Capital Management